Q2 2022 Earnings Estimate for UnitedHealth Group Incorporated Issued By Jefferies Financial Group (NYSE:UNH)

UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) – Jefferies Financial Group decreased their Q2 2022 earnings estimates for shares of UnitedHealth Group in a report issued on Sunday, April 17th. Jefferies Financial Group analyst D. Windley now expects that the healthcare conglomerate will post earnings per share of $5.17 for the quarter, down from their previous estimate of $5.25. Jefferies Financial Group also issued estimates for UnitedHealth Group’s Q3 2022 earnings at $5.61 EPS, Q4 2022 earnings at $5.43 EPS and FY2023 earnings at $24.84 EPS.

UnitedHealth Group (NYSE:UNH – Get Rating) last issued its earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, topping the consensus estimate of $5.38 by $0.11. The company had revenue of $80.15 billion during the quarter, compared to analyst estimates of $78.77 billion. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The business’s revenue was up 14.2% on a year-over-year basis. During the same quarter last year, the firm earned $5.31 EPS.

Other analysts also recently issued research reports about the company. Barclays raised their price target on UnitedHealth Group from $495.00 to $565.00 and gave the stock an “overweight” rating in a report on Wednesday, March 30th. Cowen raised their price target on UnitedHealth Group from $512.00 to $596.00 in a report on Monday. Credit Suisse Group lifted their target price on UnitedHealth Group from $564.00 to $595.00 and gave the company an “outperform” rating in a research note on Monday. Edward Jones initiated coverage on UnitedHealth Group in a research note on Monday, January 10th. They set a “buy” rating on the stock. Finally, Sanford C. Bernstein lifted their target price on UnitedHealth Group from $508.00 to $564.00 in a research note on Tuesday, January 11th. Two research analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $532.96.

Shares of NYSE UNH opened at $534.08 on Tuesday. The company has a market cap of $502.52 billion, a price-to-earnings ratio of 29.23, a price-to-earnings-growth ratio of 1.67 and a beta of 0.88. UnitedHealth Group has a 12-month low of $383.12 and a 12-month high of $553.29. The company has a current ratio of 0.78, a quick ratio of 0.79 and a debt-to-equity ratio of 0.54. The stock’s 50 day simple moving average is $499.32 and its 200 day simple moving average is $473.49.

Hedge funds and other institutional investors have recently modified their holdings of the business. Outfitter Financial LLC bought a new position in UnitedHealth Group in the 4th quarter worth approximately $25,000. Blue Bell Private Wealth Management LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at $29,000. Advocacy Wealth Management Services LLC grew its position in UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 25 shares during the period. Cascade Investment Advisors Inc. grew its position in UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 30 shares during the period. Finally, Tortoise Investment Management LLC boosted its stake in UnitedHealth Group by 54.8% in the fourth quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 23 shares in the last quarter. 86.07% of the stock is currently owned by institutional investors.

In other news, Director Paul R. Garcia purchased 2,146 shares of UnitedHealth Group stock in a transaction dated Tuesday, February 22nd. The stock was acquired at an average cost of $464.97 per share, for a total transaction of $997,825.62. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Richard T. Burke sold 4,000 shares of UnitedHealth Group stock in a transaction dated Tuesday, March 22nd. The shares were sold at an average price of $511.14, for a total value of $2,044,560.00. The disclosure for this sale can be found here. Insiders have sold a total of 23,000 shares of company stock valued at $11,123,890 over the last 90 days. Corporate insiders own 0.55% of the company’s stock.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 22nd. Shareholders of record on Monday, March 14th were given a dividend of $1.45 per share. The ex-dividend date was Friday, March 11th. This represents a $5.80 dividend on an annualized basis and a yield of 1.09%. UnitedHealth Group’s payout ratio is presently 31.75%.

About UnitedHealth Group (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles